Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28079701 | 0.93 | EPHX1 (0.35) | EPHX1TSHRPOLBHSD17B10MEN1 | |
| SCHEMBL6357368 | 0.90 | EPHX1 (0.31) | EPHX1TSHRPOLBHSD17B10MEN1 | |
| SCHEMBL28079719 | 0.88 | EPHX1 (0.32) | EPHX1TSHRPOLBHSD17B10MEN1 | |
| SCHEMBL216628 | 0.86 | EPHX1 (0.33) | EPHX1TSHRPOLBHSD17B10MEN1 | |
| SCHEMBL21551816 | 0.84 | EPHX1 (0.32) | EPHX1TSHRPOLBHSD17B10MEN1 | |
| SCHEMBL15599842 | 0.83 | — | — | |
| SCHEMBL21555659 | 0.83 | EPHX1 (0.31) | EPHX1TSHRPOLBHSD17B10MEN1 | |
| Ethylene Glycol SCHEMBL464873 | 0.83 | EPHX1 (0.39) | EPHX1TSHRPOLBHSD17B10MEN1 | |
| SCHEMBL439901 | 0.82 | TSHR (0.36) | EPHX1TSHRPOLBHSD17B10MEN1 | |
| SCHEMBL213181 | 0.81 | MEN1 (0.32) | TSHRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6967224-B2 | Resin composition and three dimensional object | DSM IP ASSETS B.V. (NL) | 2005-11-22 | — | — | US | disclosed |
| US-20040106692-A1 | Photocurable using photoinitiator | DSM N.V. (NL) | 2004-06-03 | — | — | US | disclosed |